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a  b s  t r a  c t
Objective: To evaluate the  performance of the most widely used SpA classification criteria in
a  Colombian group of patients with chronic low back pain.
Methods: We  assessed the ASAS and the European Spondyloarthropathy Study Group (ESSG)
classification criteria in a group of 133 patients who attended consecutively over a  period
of  six months at outpatient clinic of low back pain. All the patients were evaluated with
the  same protocol. The patients were divided into two groups according to the diagnosis.
The  diagnosis was compared with the diagnosis made by a  expert rheumatologist blinded
to  patient information.
Results: 81  patients with SpA and 52  with other diagnoses were included. There were no
differences in age and age of onset of symptoms between the two  groups. The SpA group
included 55  males and more common clinical findings were: enthesitis, arthritis, sacroiliitis,
HLA-B27-positive, previous infection, and dactylitis. The sensitivity and specificity of criteria
were:  ASAS criteria 96% of sensibility and 80% of specificity, and ESSG criteria 95% and 100%
respectively.
The  agreement between the classification criteria and the diagnosis established by the
rheumatologist showed a  Cohen’s kappa index of 0.938 for ESSG criteria (95% CI: 0.877–0.998)
and  0.790 for the  ASAS criteria (95% CI: 0.682–0.898).
Conclusion: In a  Colombian group of SpA patients, the new ASAS classification criteria have
a  good concordance with clinical diagnosis but are  not  superior to the ESSG criteria.
©  2017 Asociación Colombiana de Reumatologı́a. Published by Elsevier España, S.L.U. All
rights reserved.
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r  e s u m  e n
Objetivo: Evaluar el acuerdo entre los criterios de clasificación para SpA y  el diagnóstico de
un  experto reumatólogo en un grupo de pacientes con dolor lumbar.
Métodos:  Se evaluó el comportamiento de  los criterios de ASAS y  del ESSG en 133 pacientes
que  acudieron de forma consecutiva durante seis meses a  la clínica ambulatoria de  dolor
lumbar. Todos los pacientes se evaluaron con el  mismo protocolo. Los pacientes fueron
divididos en dos grupos de  acuerdo con el diagnóstico. Posteriormente se estableció del
acuerdo  diagnóstico con el de un experto reumatólogo ciego a  la información previa de  los
pacientes.
Resultados: 81 pacientes con SpA y 52  con otros diagnósticos fueron incluidos. No hubo
diferencias en la edad y la edad de aparición de  los síntomas. El grupo SpA incluyó a  55
varones y  los hallazgos más comunes fueron: entesitis, artritis, sacroileítis, infección previa,
HLA-B27, y  dactilitis. La sensibilidad y  especificidad de  los criterios fueron: ASAS 96% de
sensibilidad y  80% de especificidad, y ESSG 95% y 100% respectivamente.
El acuerdo entre los criterios de clasificación y  el  diagnóstico del reumatólogo mostró un
índice kappa de  0,938 con criterios ESSG (IC del 95%: 0,877–0,998) y  0,790 para los criterios
ASAS (IC del 95%: 0,682–0,898).
Conclusión: En un grupo de pacientes colombianos SpA, los nuevos criterios de  clasificación
ASAS tienen una buena concordancia con el diagnóstico clínico, pero no son superiores a
los  criterios ESSG.
©  2017 Asociación Colombiana de  Reumatologı́a. Publicado por  Elsevier España, S.L.U.
Todos  los derechos reservados.
Introduction
Spondyloarthritis (SpA) are a group of chronic inflamma-
tory disorders that share clinical, radiological, HLA-B27
association, positive family history and pathophysiological
characteristics. SpA affect approximately 1.5% of the general
population. Predominantly, SpA begins in individuals younger
than 45 years and clinically compromises the axial spine,
peripheral joints, tendons and ligament insertions (entheses),
having also extra-musculoskeletal manifestations in the  skin,
mucosa, gut and the eyes, producing impairment of functional
capacity.1 The incidence of SpA in the  general population is
related to the prevalence of HLA-B27. This explains why SpA is
most commonly diagnosed in Anglo-Saxon populations where
the prevalence of HLA-B27 could reach up  to  14%.2
One of the clinical manifestations present in  all stages
of the disease, is  inflammatory back pain (IBP).3 In clinical
practice is difficult to  differentiate between the mechani-
cal or inflammatory origin of pain. Traditionally clinical and
epidemiological studies have used classification criteria to
identify the two groups of patients. The frequency of inflam-
matory back pain has been estimated at 5% of all patients
with chronic low back pain (CLBP).4 At the same time, the
CLBP is the most common cause of disability in  men  between
15 and 45 years of age and it is important to differentiate
between the sources of pain given the prognostic and ther-
apeutic implications.5
In the  last 30  years, several classification criteria for SpA
have attempted to include the early stages as  well  as the undif-
ferentiated forms of the disease (uSpA).6–10 According to the
European Spondyloarthropathy Study Group (ESSG) criteria,
SpA has been traditionally classified as  follows: ankylos-
ing spondylitis (AS), reactive arthritis (ReA), undifferentiated
spondyloarthritis (uSpA), psoriatic arthritis (PsA), and arthritis
associated with inflammatory bowel disease (IBD).7
The Assessment of Spondyloarthritis International Society
(ASAS) proposes a new classification criteria that includes
two sets; axial and peripheral according to the prevalence
of symptoms. The new ASAS criteria include the  use of MRI  of
the sacroiliac joints and HLA-B27 as a  fundamental part
of the diagnosis.8,10
There is no gold standard for the diagnosis of SpA because
of the heterogeneity of the musculoskeletal symptoms.11
Sometimes epidemiological classification criteria are used as a
tool in the diagnosis of these diseases with acceptable clinical
performance.12 However, the results may vary depending on
the prevalence of the disease. In the Latin American countries
uSpA corresponds to the most common form of presenta-
tion, with predominance of a  mixture of axial and peripheral
symptoms, low frequency of HLA-B27 and with less radio-
logical (joint) damage of the axial skeleton.13–15 Other HLA
molecules have been implicated as responsible for this vari-
ation in clinical presentation. In routine clinical practice, the
diagnostic decision depends exclusively on the experience of
the rheumatologist who assesses the patient.16
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The objective of this study is to establish an agreement
between the most widely used classification criteria and a
rheumatologist’s diagnosis in a  group of Colombian patients.
Materials  and  methods
Participants  and  clinical  assessment  of  patients
A total of 133 patients, >18 years, with past or current history of
CLBP (≥3 months) occurring before age 45 years, who attended
consecutively over a  period of six months at outpatient clinic
of CLBP were included in  the study. These patients were
referred by other medical specialties: general practitioner,
family medicine, internal medicine, orthopedics, rehabilita-
tion medicine and neurosurgery. All patients underwent in the
same diagnostic algorithm that included the use of a struc-
tured questionnaire completed by the rheumatologist from
the available data at the time of visit with socio-demographic
information; history related to pain: date of the onset, trig-
ger,  morning stiffness, insidious onset, improved with the
exercise, worsening with rest, awakening at night because of
pain, good response to no steroidal anti-inflammatory drugs,
degree of disability by pain, cervical and thoracic spine com-
promise, button pain; history of arthritis, enthesitis, dactilitys;
personal and family history related to the SpA: infections,
uveitis, psoriasis or inflammatory bowel disease. All patients
were applied specific instruments related to functional sta-
tus and activity of the SpA: BASFI,17 BASDAI,18 visual analog
scale (VAS) of pain and disease activity. For the  physical exam-
ination ASAS recommendations were followed and included:
occiput to wall  distance, thoracic expansibility, Shober test,
painful enthesis account by Mander’s Index and tender and
swollen joints account on a  total of 44. HLA  typing, PCR and
VSG.19
Imaging
All patients underwent MRI  of sacroiliac joints using contrast
agents and fat suppression techniques (projections in T1, T2
and STIR), radiographs of the pelvis. All images were evalu-
ated by a radiologist with experience in SpA who remained
blinded to the clinical information of the patients. Sacroiliitis
by images was  defined by New York and ASAS criteria for X-
ray and MRI  respectively. Pre-radiographic sacroiliitis in cases
of normal pelvic X-ray with sacroiliitis evidence by MRI.20
Diagnosis  and  classification  of  patients
Finally, an expert rheumatologist in the field of SpA evalu-
ated independently the clinical and laboratory findings of the
patients and divided the patients into the two groups: SpA
and none SPA. No SpA patients were diagnosed with different
pathologies: osteoarthritis, postural syndrome, rheumatoid
arthritis and fibromyalgia SpA. Using the expert opinion as
gold standard for diagnosis of SpA, the  operation (sensitivity
and specificity) of the EGSS and ASAS criteria were established.
In addition, the degree of agreement between the ESSG and
the ASAS classification criteria with clinical diagnosis, was
calculated using the kappa index.
Statistics
Data analysis was performed using Stata 10.0. Measures of
central tendency and dispersion for the continuous variables
were used for data presentation. Frequency and percentage
values were used for the  categorical variables. The Student’s
t-test and the Kruskal–Wallis test were used to  compare
the continuous variables. For the nominal variables, the chi-
squared test was used, and Fisher’s exact test was  used if
necessary. In this study, p < 0.05 was considered statistically
significant, and 95% confidence intervals (CIs) were calculated.
Ethics  approval
The study followed the norms established by the Helsinki Dec-
laration, The Guidelines for Good Clinical Practice, and the
Resolution 8430 (1993) of the Colombian Ministry for Social
Protection. Moreover, was reviewed and approved by the Ethics
Committees of the University of La Sabana and the Central Mil-
itary Hospital. Each patient signed an informed consent form,
and confidentiality was  strictly maintained.
Results
A  total of 133 patients were included, 81 patients with SpA and
52 none SpA. Of SpA patients, 33 (40.7%) had AS, 32 (39.5%)
uSpA and 16 (19.8%) ReA. 55  (67.9%) were males, with a  ratio
male/female of 2:1. The more  frequent clinical manifestations
were IBP, and enthesopathy. In none SpA patients, 24 had
postural syndrome, 14 fibromyalgia, 12 osteoarthritis and two
rheumatoid arthritis.
There was  no significant difference between the two groups
of patients in age at the  onset of symptoms, disease duration,
age at the time of evaluation and indices of function and activ-
ity of disease. HLA-B27 was present in 42% of the patients with
SpA (57.6% in AS, 18.8% in uSpA and 56.3% in ReA) and only
in 3.8% of the patients with other diseases (p < 0.001). In terms
of clinical characteristics, there were significant differences
in all variables. Arthritis and uveitis were more  common in
SpA patients and were associated with HLA-B27 allele. Blood
markers of inflammation were more  elevated in  patients with
SpA than in controls (p =  0.005). IBP, enthesopathy, blood and
radiological evidence of sacroiliitis, were the variables with
more significance in SpA (Table 1).
X-ray  and  MRI  results
In the patients with SpA, the pelvic X-ray showed evidence
of sacroiliitis in 44%, compared with 43% with MRI. Sacroili-
itis in  the X-ray was strongly correlated with SpA 44.4% vs
15.4% (p = 0.001) and was present in  33  (100%) of the  patients
with AS, 2  patients with uSpA (6.25%) and 1 patient with ReA
(6.25%) and 8  (15.4%) non-SpA patients. The MRI  was positive
in (35/81) 43.2% of the SpA patients and (6/52) 11.5% of non-SpA
patients (p = 0.000). MRI  provided evidence of pre-radiographic
sacroiliitis in 10 of the 30 patients with uSpA (33.3%) and 5 of
the 15  patients with ReA (33.3%). Furthermore, the MRI  showed
pre-radiographic sacroiliitis in  6 patients in  the control group,
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Table 1 – Clinical characteristics of the evaluated patients.
All patients (n  = 133) SpA (n = 81) Non SpA (n = 52) p
Age in years, mean (SD) 33.7 (10.3) 33.6 (11.2) 33.9 (8.7)
Age in years at the  onset of symptoms, mean (SD) 27.6 (8.1) 26.6 (7.6) 29.2 (8.7) 0.070
Males 24.6 (6.2)
Females 31.1 (8.6)
Disease duration (y), mean ± SD 5.8 (7.0) 6.5 ±  8.3 4.7 ± 4.3
Male gender, % 66.9 67.9 65.4
HLA-B27, % 27.1  42  3.8 0.001
Family history  of SpA, % 3.0  4.9 0.0
ESR, mm/h (SD) 12.9  (11.3) 15.5 (12.1) 9.5 (9.1) 0.005
C-reactive protein, g/dl, mean  ± SD 1.2 ±  3.0 1.8 ±  3.7 0.4 ± 1.2  0.023
**BASDAI 5.5 ±  2.0 6.1 ±  2.0 4.6 ± 1.8  0.001
***BASFI 5.0 ±  2.3 5.6 ±  2.2 4.1 ± 2.2  0.001
General patient*VAS 6.1 ±  2.3 6.4 ±  2.3 5.8 ± 2.2  0.110
General physician*VAS  3.8 ±  2.3 5.1 ±  2.0 1.8 ± 0.9  0.001
Sacroiliitis evidenced by radiography (%) 44 (33.1) 36  (44.4) 8 (15.4) 0.001
Active inflammation in sacroiliac joints (MRI)% 12 (21.3) 27  (33.3) 6 (11.5) 0.009
Sacroiliitis by X-ray or MRI  63 (47.4) 51  (63) 12 (23.1)
∗ VAS =  Visual Analog Scale.
∗∗ Bath Ankylosing Spondylitis Disease Activity Index.
∗∗∗ Bath Ankylosing Spondylitis Functional Index; MRI:  Magnetic Resonance Image, ESR: Erythrocyte sedimentation rate
Table 2 – Agreement between the classification criteria and the clinical diagnoses.
ASAS SpA  Others Total ESSG SpA Others Total
Does not meet 3 42 45 Does not  meet 4 52  56
Meets 78  10 88 Meets 77 0 77
Total 81  52 133 Total 81 52  133
of whom only 1 patient had similar radiographical findings
(Table 1).
Performance  of  the ESSG  and  ASAS  classification  criteria
When we  analyzed the performance of the ESSG criteria in
this population, we  found that 95% of the SpA patients met
the criteria. None of the non-SpA patients met  the criteria. The
results also showed that 96.3% of the SpA patients and 19.2% of
the non-SpA patients met  the  new ASAS criteria. ASAS criteria
have 96% of sensibility and 80% of specificity, and ESSG criteria
95% and 100%, respectively.
When we  analyzed the agreement of the classification
criteria with the diagnosis established by the rheumatologist,
we found a Cohen’s kappa index of 0.938 for the ESSG criteria
(95% CI: 0.877–0.998) and 0.790 for the ASAS criteria (95% CI:
0.682–0.898) (Table 2).
Discussion
The population described here is a sample of patients who
suffer from different forms of SpA. All of the patients were
recruited during outpatient consultations at the  Rheuma-
tology Department of one national referral hospitals for
highly complex diseases. These patients were referred to the
Department after having been evaluated by other medical
specialties (Orthopedics, Rehabilitation Medicine, Neuro-
surgery, Ophthalmology and Internal Medicine), when SpA
was  established as a possible diagnosis due to the presence
of chronic low back pain.
As described in other populations, the predominant
symptoms among the SpA patients were lower back pain,
arthritis and enthesopathy. Other symptoms such as dactyli-
tis and uveitis were observed in  the same proportions
reported in previous studies.9,21 In the  non-SpA patients,
the most common symptoms were chronic lower back
pain and gluteal pain. The time of disease progression
was lower in our group of patients than that reported
by Feldtkeller in 2003 (6.5 ± 8.3 years vs. 8.8 ±  7.6 years,
respectively).22
HLA-B27 was present in  a  smaller proportion of our
patients (42%) compared with other populations. Although
this lower prevalence seems to be the trend in current publica-
tions, the lower prevalence may  reflect the racial composition
of our population and the relatively high number of patients
with undifferentiated and reactive forms of the  disease.21 In
this study, 28  patients fulfilled the new ASAS criteria with axial
involvement: 24 patients met  the radiological requirement
and 15 patients met  the requirement contingent on a posi-
tive HLA-B27 test (11 patients met  both requirements; thus,
4 patients were only positive for HLA-B27, and 13 patients
only had images showing sacroiliitis). This difference is an
important detail because it appears that imaging offered
better results for patient classification than HLA-B27 char-
acterization, with a better performance of plain radiography
for sacroiliitis diagnosis than MRI in  our study. However, in
this group of patients, HLA-B27 positivity was strongly asso-
ciated with the clinical markers traditionally considered to  be
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associated with more  severe forms of the disease (AS, uveitis
and arthritis).
As reported by Weber, non-SpA patients may  have positive
results in the MRI  of the sacroiliac joints and spine. Healthy
controls can have isolated foci of hyperintensity on STIR (bone
pseudo-edema) with a  frequency close to 27%.23,24 The other
hand, arthrosis is  common condition in  patients over 40 years
old. It can cause unilateral or bilateral, symmetrical or asym-
metrical sacroiliac joint inflammation.25 This conditions could
explain why several of our patients in whom SpA was ruled
out had positive MRI  results (n  = 6) and justifies the increase in
the number of false positives that resulted from using this set
of criteria. When the sacroiliac joint MRI results were com-
bined with the ESSG criteria, 1 additional patient met  the
requirements for SpA. These data may  justify reconsidering
the use of this diagnostic method in patients with a  diagnosis
of uSpA because the other clinical and laboratory criteria can
provide the necessary diagnostic information. This uncom-
mon pre-radiographic sacroiliitis suggests a better prognosis
in our population, with less likelihood of progression to AS,
which is the more  severe form of SpA. However, this progres-
sion must be examined using a  different study design in  larger
patient populations.
Nevertheless, after reviewing the most recent literature on
this regard Banegas Illescas and collaborators conclude that
the ASAS criteria have limitations concerning the diagnos-
tic and prognostic utility of MRI  in these patients. Firstly, in
absence of bone edema or  osteitis the MRI-identified struc-
tural lesions are  not diagnostic of sacroilitis. This exclusion
is contradictory due to the fact that the other radiological
marker of sacroiliitis is based on structural changes seen on
the simple X-ray according to New York new modified criteria
despite the great inter-observer variability.26–28 Several trials
have shown that MRI  is  not only capable of finding structural
lesions before they can be seen on the X-ray without active
inflammatory lesions,24,29 but it is also capable of increasing
its diagnostic sensibility from 67% to 81%, when erosions are
analyzed besides bone edema without changes in specificity
(88%).24
Considering these observations, the agreement between
the classification criteria and the clinical diagnosis was good
in this group of patients and also highlighted a  better inter-
pretation of the ESSG criteria.
The results obtained in this study should be analyzed with
the understanding that there is a  higher proportion of reac-
tive and undifferentiated forms of SpA in Latin American
patients than in Anglo-Saxon populations. In our populations,
peripheral manifestations are predominant compared with
axial involvement, and the prevalence of HLA-B27 is low as
a result of miscegenation.
The patients who were evaluated and participated in this
study were referred to  the SpA clinic after an  outpatient con-
sultation at the Department of Rheumatology of one tertiary
care hospital that are the  national referral center for a  popula-
tion of over half a million people. This referral creates a  filter so
that the patients included in this study represented the  most
severe forms of the disease. This meant that only patients with
more complex were evaluated by the rheumatologist, causing
a selection bias. For this reason, the number of patients with
SpA is significantly higher than the other diseases. However,
in the context of the objective of the present study, the sam-
ple size, allowed the agreement between the  clinical diagnosis
in real life of outpatient care of patients and the classifica-
tion criteria for SpA used most frequently. This explains why
the performance of the classification criteria is  greater than
previously reported in  open community.30–32 Therefore, it  is
necessary to study in Latin-American countries which really
is the performance ESSG and ASAS criteria, where the percent-
age of patients with HLA-B27 positive and axial compromise
is smaller compared with Anglo-Saxon populations.33,34
In conclusion, the ESSG and ASAS classification criteria and
the clinical diagnosis made by expert rheumatologists were
well correlated in the Colombian population. However, in the
present study, the ESSG criteria showed a higher degree of
agreement with clinical diagnosis, which should be analyzed
in other Latin American populations.
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